12
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T61211 |
5-LOX-IN-1
|
Lipoxygenase | Metabolism |
5-LOX-IN-1 是一种 5-Lipoxygenase(5-LOX)抑制剂(IC50: 2.3 μM)。5-LOX-IN-1 可用于研究癌症。 | |||
T60630 |
COX/5-LOX-IN-1
|
||
COX/5-LOX-IN-1 (compound 6b) 是有效的COX/5-LOX 双重抑制剂,具有用于炎症性疾病研究的潜力。COX/5-LOX-IN-1 对于 COX-1、COX-2 和 5-LOX 酶的IC50值分别为 1.07、0.55 和 0.28 μM。 | |||
T61674 |
COX-2/5-LOX-IN-1
|
||
COX-2/5-LOX-IN-1 (compound 3a), a benzothiophen-2-yl pyrazole carboxylic acid derivative, is a potent and dual inhibitor of COX-2 / 5-LOX. It exhibits superior analgesic and anti-inflammatory properties compared to Celecoxib and Indomethacin. COX-2/5-LOX-IN-1 displays strong inhibitory activity against COX-1, COX-2, and 5-LOX, with IC50 values of 12.13 μM, 0.4 μM, and 4.96 μM, respectively [1]. | |||
T21838 |
1-Naphthyl 3,5-dinitrobenzoate
JMC-4 |
Lipoxygenase | Metabolism |
1-Naphthyl 3,5-dinitrobenzoate (JMC-4) 是 5-LOX 的抑制剂,可用于炎症治疗的研究。 | |||
T61352 |
COX-2/5-LOX-IN-3
|
||
COX-2/5-LOX-IN-3 (compound 5b) is a powerful and dual inhibitor of COX-2 and 5-LOX, with IC50 values of 45.73 μM, 5.45 μM, and 4.33 μM for COX-1, COX-2, and 5-LOX, respectively. This compound, COX-2/5-LOX-IN-3, shows promise for the investigation of inflammatory diseases [1]. | |||
T78820 |
5-LOX-IN-5
|
Lipoxygenase | Metabolism |
5-LOX-IN-5(Compound 29)作为一种5-LOX抑制剂,拥有56 nM的半抑制浓度(IC50)。它主要被应用于神经退行性疾病的研究领域。 | |||
T61910 |
COX-2/5-LOX-IN-2
|
||
COX-2/5-LOX-IN-2 是苯并噻吩-2-基吡唑羧酸衍生物。COX-2/5-LOX-IN-2 (5b) 对COX-2和5-LOX 均有抑制作用。COX-2/5-LOX-IN-2 抑制 COX-1、COX-2 和 5-LOX 的IC50s 分别为 5.40、0.01 和 1.78 μM。COX-2/5-LOX-IN-2 显示出超过塞来昔布和吲哚美辛的镇痛和抗炎活性。 | |||
T81181 | sEH/FLAP-IN-1 | FLAP | Immunology/Inflammation |
sEH/FLAP-IN-1(Compound 46A)是一sEH/FLAP抑制剂,具有阻断SACM刺激PBMC中5-LOX产物形成的活性(EC50: 11 nM),并能抑制sEH活性(EC50: 18 nM)及血栓素产生。该化合物适用于炎症性疾病研究领域。 | |||
T78706 |
COX-2-IN-31
|
COX | Immunology/Inflammation; Neuroscience |
COX-2-IN-31(化合物7b)是一种COX/5-LOX双重抑制剂,口服活性显著,对COX-2的IC50为60 nM,对5-LOX的IC50为0.9 μM。此外,COX-2-IN-31对跨膜蛋白hCA IX和hCA XII具有抑制作用,其Ki值分别为48.9 nM和5.8 nM,显示出镇痛和抗炎的生物活性。 | |||
T22172 |
YS-121
|
||
YS121 是微粒体前列腺素 E2 合酶-1 (mPGES-1;IC50=3.4 μM) 和 5-脂氧合酶 (5-LOX;IC50=6.5 μM) 的双重抑制剂。在 IL-1β 刺激的 A549 细胞中,YS121以剂量依赖性地方式减少 PGE2 的产生,EC50为 12 μM。 | |||
T78705 |
COX-2-IN-30
|
COX | Immunology/Inflammation; Neuroscience |
COX-2-IN-30 是苯磺酰胺衍生的口服活性 COX/5-LOX 双重抑制剂,其 IC50 值为 COX 同源物为 49 nM、5-LOX 同源物为 10.4 μM。此化合物还能纳摩尔级别 Ki 值抑制 hCA IX 与 hCA XII 亚型。COX-2-IN-30 具备镇痛、抗炎、致溃疡作用,不引发急性胃部反应。 | |||
T37805 |
JKE-1716
|
||
JKE-1716 is an inhibitor of glutathione peroxidase 4 (GPX4) and a derivative of the GPX4 inhibitor ML-210 .1JKE-1716 reduces viability of LOX-IMVI cancer cells in a concentration-dependent manner and in a panel of additional cancer cell lines, an effect that can be blocked by the ferroptosis inhibitor ferrostatin-1 . 1.Eaton, J.K., Furst, L., Ruberto, R.A., et al.Selective covalent targeting of GPX4 using masked nitrile-oxide electrophilesNat. Chem. Biol.16(5)497-506(2020) |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6S0413 |
Pectolinarigenin
柳穿鱼黄素,Pectolinaringenin |
Others; Lipoxygenase; COX | Immunology/Inflammation; Metabolism; Neuroscience; Others |
Pectolinarigenin (Pectolinaringenin) 是 COX-2/5-LOX 的双重抑制剂,可抑制炎症病变中类花生酸的形成,具有抗炎活性。 |